{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:35:45Z","timestamp":1794436545772,"version":"4.9.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.molmet.2025.102225","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T23:50:33Z","timestamp":1753919433000},"page":"102225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["DIO3 depletion attenuates ovarian cancer growth via reduced glycolysis and alterations in glutamine metabolism"],"prefix":"10.1016","volume":"100","author":[{"given":"Dotan","family":"Moskovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Beilinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Rosemarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itai","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzuri","family":"Lifschytz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Lerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govindasamy","family":"Mugesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Gottfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8624-3182","authenticated-orcid":false,"given":"Osnat","family":"Ashur-Fabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2025.102225_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188563","article-title":"Recent advancements in therapeutic targeting of the Warburg effect in refractory ovarian cancer: a promise towards disease remission","author":"Tyagi","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"10.1016\/j.molmet.2025.102225_bib2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1186\/s12967-024-05770-y","article-title":"Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer","volume":"22","author":"Cui","year":"2024","journal-title":"J Transl Med"},{"issue":"5930","key":"10.1016\/j.molmet.2025.102225_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.molmet.2025.102225_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051056","article-title":"Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation","volume":"10","author":"Schiliro","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.molmet.2025.102225_bib5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.molmet.2025.102225_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.copbio.2021.03.001","article-title":"Glutathione and its precursors in cancer","volume":"68","author":"Asantewaa","year":"2021","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.molmet.2025.102225_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100797","article-title":"Impact of cancer metabolism on therapy resistance - clinical implications","volume":"59","author":"Gon\u00e7alves","year":"2021","journal-title":"Drug Resist Updates"},{"issue":"3","key":"10.1016\/j.molmet.2025.102225_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.60","article-title":"Targeting cellular metabolism to improve cancer therapeutics","volume":"4","author":"Zhao","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.molmet.2025.102225_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.canlet.2020.11.011","article-title":"DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer","volume":"501","author":"Moskovich","year":"2021","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.molmet.2025.102225_bib10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.molmet.2025.102225_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/0008-5472.CAN-15-1382","article-title":"It\u2019s totally Tubular....Riding the new wave of ovarian cancer research","volume":"76","author":"Perets","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.molmet.2025.102225_bib12","first-page":"1","article-title":"Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment","author":"Moskovich","year":"2021","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.molmet.2025.102225_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/ERC-11-0329","article-title":"Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients","volume":"19","author":"Gy\u0151rffy","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"10.1016\/j.molmet.2025.102225_bib14","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1002\/ijc.32369","article-title":"ROCplot. org: validating predictive biomarkers of chemotherapy\/hormonal therapy\/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients","volume":"145","author":"Fekete","year":"2019","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.molmet.2025.102225_bib15","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41596-022-00710-w","article-title":"Using MetaboAnalyst 5.0 for LC\u2013HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data","volume":"17","author":"Pang","year":"2022","journal-title":"Nat Protoc"},{"issue":"23","key":"10.1016\/j.molmet.2025.102225_bib16","doi-asserted-by":"crossref","first-page":"8488","DOI":"10.1073\/pnas.1314810111","article-title":"Visual account of protein investment in cellular functions","volume":"111","author":"Liebermeister","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2025.102225_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ncomms1137","article-title":"Systems-wide temporal proteomic profiling in glucose-starved Bacillus subtilis","volume":"1","author":"Otto","year":"2010","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2025.102225_bib18","series-title":"2009 sixth international symposium on voronoi diagrams","first-page":"233","article-title":"Visualizing gene expression data via Voronoi treemaps","author":"Bernhardt","year":"2009"},{"key":"10.1016\/j.molmet.2025.102225_bib19","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1038\/ncomms7001","article-title":"Fumarate induces redox-dependent senescence by modifying glutathione metabolism","volume":"6","author":"Zheng","year":"2015","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.molmet.2025.102225_bib20","first-page":"233","article-title":"ES-2 ovarian cancer cells present a genomic profile inconsistent with their reported history","volume":"4","author":"Devor","year":"2021","journal-title":"Obstetr Gynecol Res"},{"key":"10.1016\/j.molmet.2025.102225_bib21","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat Commun"},{"issue":"28","key":"10.1016\/j.molmet.2025.102225_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2201423119","article-title":"Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases","volume":"119","author":"Duru","year":"2022","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10.1016\/j.molmet.2025.102225_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10545-011-9382-9","article-title":"Mitochondrial ATP synthase: architecture, function and pathology","volume":"35","author":"Jonckheere","year":"2012","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"10.1016\/j.molmet.2025.102225_bib24","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040535","article-title":"Glycolysis","volume":"13","author":"Chandel","year":"2021","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"9","key":"10.1016\/j.molmet.2025.102225_bib25","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J Clin Investig"},{"key":"10.1016\/j.molmet.2025.102225_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mito.2014.09.002","article-title":"ATP\/ADP ratio, the missed connection between mitochondria and the Warburg effect","volume":"A","author":"Maldonado","year":"2014","journal-title":"Mitochondrion 19 Pt"},{"issue":"1","key":"10.1016\/j.molmet.2025.102225_bib27","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41467-023-36755-y","article-title":"Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage","volume":"14","author":"Nappi","year":"2023","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.molmet.2025.102225_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.7555\/JBR.34.20190037","article-title":"Glutamate in cancers: from metabolism to signaling","volume":"34","author":"Yi","year":"2019","journal-title":"J Biomed Res"},{"key":"10.1016\/j.molmet.2025.102225_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/srep16950","article-title":"Structure of human carbamoyl phosphate synthetase: deciphering the on\/off switch of human ureagenesis","volume":"5","author":"de Cima","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.molmet.2025.102225_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cbf.1000","article-title":"Effect of arginine, ornithine and citrulline supplementation upon performance and metabolism of trained rats","volume":"21","author":"Meneguello","year":"2003","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"10.1016\/j.molmet.2025.102225_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbrc.2009.10.168","article-title":"Cancer cells release glutamate via the cystine\/glutamate antiporter","volume":"391","author":"Sharma","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.molmet.2025.102225_bib32","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","article-title":"Glutathione synthesis","volume":"1830","author":"Lu","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.molmet.2025.102225_bib33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1593\/neo.08120","article-title":"Different mutant\/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells","volume":"10","author":"Junk","year":"2008","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.molmet.2025.102225_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41419-022-04730-y","article-title":"CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma","volume":"13","author":"Tang","year":"2022","journal-title":"Cell Death Dis"},{"issue":"19","key":"10.1016\/j.molmet.2025.102225_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194696","article-title":"The \u201csweet spot\u201d of targeting tumor metabolism in ovarian cancers","volume":"14","author":"Tondo-Steele","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.molmet.2025.102225_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010033","article-title":"Ovarian cancer relies on glucose transporter 1 to fuel glycolysis and growth: anti-tumor activity of BAY-876","volume":"11","author":"Ma","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.molmet.2025.102225_bib37","doi-asserted-by":"crossref","first-page":"R367","DOI":"10.1530\/ERC-17-0192","article-title":"Role of thyroid hormones in the neoplastic process: an overview","volume":"24","author":"Goemann","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"10.1016\/j.molmet.2025.102225_bib38","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/15548627.2015.1061849","article-title":"Thyroid hormone induction of mitochondrial activity is coupled to mitophagy via ROS-AMPK-ULK1 signaling","volume":"11","author":"Sinha","year":"2015","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.molmet.2025.102225_bib39","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jhep.2019.12.018","article-title":"Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming","volume":"72","author":"Kowalik","year":"2020","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.molmet.2025.102225_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.20463\/jenb.2016.06.20.2.5","article-title":"Characterization of the metabolic effect of \u03b2-alanine on markers of oxidative metabolism and mitochondrial biogenesis in skeletal muscle","volume":"20","author":"Schnuck","year":"2016","journal-title":"J Exerc Nutrition Biochem"},{"issue":"6","key":"10.1016\/j.molmet.2025.102225_bib41","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF03402159","article-title":"Human mitochondrial transcription factor A reduction and mitochondrial dysfunction in Hashimoto\u2019s hypothyroid myopathy","volume":"8","author":"Siciliano","year":"2002","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.molmet.2025.102225_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1113\/eph8802506","article-title":"Regulation of mitochondrial biogenesis by thyroid hormone","volume":"88","author":"Weitzel","year":"2003","journal-title":"Exp Physiol"},{"issue":"9","key":"10.1016\/j.molmet.2025.102225_bib43","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/1097-0061(20000630)16:9<797::AID-YEA553>3.0.CO;2-5","article-title":"The importance of ATP as a regulator of glycolytic flux in Saccharomyces cerevisiae","volume":"16","author":"Larsson","year":"2000","journal-title":"Yeast"},{"key":"10.1016\/j.molmet.2025.102225_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13578-019-0317-8","article-title":"PKM2, function and expression and regulation","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci"},{"issue":"1","key":"10.1016\/j.molmet.2025.102225_bib45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","article-title":"NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"issue":"5","key":"10.1016\/j.molmet.2025.102225_bib46","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.molmet.2025.102225_bib47","article-title":"The protective role of nutritional antioxidants against oxidative stress in thyroid disorders","volume":"13","author":"Macvanin","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.molmet.2025.102225_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/218145","article-title":"The role of thyroid hormones as inductors of oxidative stress and neurodegeneration","volume":"2013","author":"Villanueva","year":"2013","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"10.1016\/j.molmet.2025.102225_bib49","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41416-020-01156-1","article-title":"Cysteine metabolic circuitries: druggable targets in cancer","volume":"124","author":"Bonif\u00e1cio","year":"2021","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.molmet.2025.102225_bib50","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/ars.2011.4391","article-title":"The cystine\/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities","volume":"18","author":"Lewerenz","year":"2013","journal-title":"Antioxidants Redox Signal"},{"issue":"18","key":"10.1016\/j.molmet.2025.102225_bib51","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1016\/j.molcel.2021.08.005","article-title":"The context-specific roles of urea cycle enzymes in tumorigenesis","volume":"81","author":"Hajaj","year":"2021","journal-title":"Mol Cell"},{"issue":"9","key":"10.1016\/j.molmet.2025.102225_bib52","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051981","article-title":"N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages","volume":"22","author":"Menga","year":"2021","journal-title":"EMBO Rep"},{"issue":"1","key":"10.1016\/j.molmet.2025.102225_bib53","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1096\/fj.201902155R","article-title":"Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling","volume":"34","author":"Bhedi","year":"2020","journal-title":"FASEB J"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877825001322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877825001322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T23:01:02Z","timestamp":1758668462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877825001322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":53,"alternative-id":["S2212877825001322"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2025.102225","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DIO3 depletion attenuates ovarian cancer growth via reduced glycolysis and alterations in glutamine metabolism","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2025.102225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102225"}}